Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2005;96:958-964
Published online before print April 14, 2005, doi: 10.1161/01.RES.0000166924.31219.49
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
96/9/958    most recent
01.RES.0000166924.31219.49v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mehrhof, F. B.
Right arrow Articles by Scheidereit, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mehrhof, F. B.
Right arrow Articles by Scheidereit, C.
Related Collections
Right arrow Pathophysiology
Right arrow Cell signalling/signal transduction
Right arrow Gene regulation
Right arrow Smooth muscle proliferation and differentiation
(Circulation Research. 2005;96:958.)
© 2005 American Heart Association, Inc.


Molecular Medicine

Regulation of Vascular Smooth Muscle Cell Proliferation

Role of NF-{kappa}B Revisited

Felix B. Mehrhof, Ruth Schmidt-Ullrich, Rainer Dietz, Claus Scheidereit

From the Medizinische Klinik mit Schwerpunkt Kardiologie (F.B.M., R.D.), Universitätsklinikum Charité, Campus Virchow Klinikum, Berlin; and Max-Delbrück-Centrum for Molecular Medicine (F.B.M., R.S.-U., R.D., C.S.), Berlin, Germany

Correspondence to Claus Scheidereit, Max-Delbrück-Centrum for Molecular Medicine, Robert-Rössle-Str. 10, 13125 Berlin, Germany. E-mail scheidereit{at}mdc-berlin.de

The transcription factor NF-{kappa}B regulates cell cycle progression and proliferation in a number of cell types. An important unresolved issue is the potential role of NF-{kappa}B in the proliferation of vascular smooth muscle cells (VSMCs) as a basis for the development of vascular disease. To investigate the contribution of NF-{kappa}B to mitogen-induced proliferation of VSMCs, a knock-in mouse model expressing the NF-{kappa}B superrepressor I{kappa}B{alpha}{Delta}N (cI{kappa}B{alpha}{Delta}N) was used. Comparing wild-type and I{kappa}B{alpha}{Delta}N-expressing VSMCs, we found that proliferation rates did not differ after mitogenic stimulation by platelet-derived growth-factor-BB (PDGF-BB) or serum. In line with this, NF-{kappa}B activation was not observed in VSMCs derived from transgenic mice expressing an NF-{kappa}B–dependent lacZ reporter (c(Igk)3conalacZ). We further show, that classical mitogenic signaling pathways (namely mitogen-activated protein kinase [MAPK] and the phosphatidyl-inositol-3-OH-kinase [PI3K] pathways) control VSMC proliferation, but independently of NF-{kappa}B activation. In contrast to VSMCs, mouse embryonic fibroblasts (MEFs) derived from I{kappa}B{alpha}{Delta}N-expressing mice showed significantly impaired proliferation rates after mitogenic stimulation. This was reflected by strongly impaired cyclin D1 expression in serum-stimulated MEFs derived from (cI{kappa}B{alpha}{Delta}N) mice. These results implicate that essential pathogenetic functions of NF-{kappa}B in the development of atherosclerosis involve apoptotic and inflammatory signaling of VSMCs rather than proliferation. They further provide genetic evidence for a cell-type restricted requirement of NF-{kappa}B in the control of cellular proliferation.


Key Words: VSMC proliferation • atherosclerosis • NF-{kappa}B • PI3K • MAPK




This article has been cited by other articles:


Home page
EndocrinologyHome page
K. V. Ramana, R. Tammali, A. B. M. Reddy, A. Bhatnagar, and S. K. Srivastava
Aldose Reductase-Regulated Tumor Necrosis Factor-{alpha} Production Is Essential for High Glucose-Induced Vascular Smooth Muscle Cell Growth
Endocrinology, September 1, 2007; 148(9): 4371 - 4384.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Y. Chen, R. C. Budd, R. J. Kelm Jr, B. E. Sobel, and D. J. Schneider
Augmentation of Proliferation of Vascular Smooth Muscle Cells by Plasminogen Activator Inhibitor Type 1
Arterioscler. Thromb. Vasc. Biol., August 1, 2006; 26(8): 1777 - 1783.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Giordano, R. Avellino, P. Ferraro, S. Romano, N. Corcione, and M. F. Romano
Rapamycin antagonizes NF-{kappa}B nuclear translocation activated by TNF-{alpha} in primary vascular smooth muscle cells and enhances apoptosis
Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2459 - H2465.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. J. Son, S. J. Ha, H. S. Song, Y. Lim, Y. P. Yun, J. W. Lee, D. C. Moon, Y. H. Park, B. S. Park, M. J. Song, et al.
Melittin Inhibits Vascular Smooth Muscle Cell Proliferation through Induction of Apoptosis via Suppression of Nuclear Factor-{kappa}B and Akt Activation and Enhancement of Apoptotic Protein Expression
J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 627 - 634.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
R. Schmidt-Ullrich, D. J. Tobin, D. Lenhard, P. Schneider, R. Paus, and C. Scheidereit
NF-{kappa}B transmits Eda A1/EdaR signalling to activate Shh and cyclin D1 expression, and controls post-initiation hair placode down growth
Development, March 15, 2006; 133(6): 1045 - 1057.
[Abstract] [Full Text] [PDF]